Table 2.
Comparison of effects omega-3 fatty acid supplementation with placebo controlled on cardiorespiratory fitness (CRF) parameters.
| Variable | MCT (n = 12) Mean ± SD |
OMEGA (n = 14) Mean ± SD |
ALL (n = 26) Mean ± SD |
|||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| OUE [mL*L−1] | 35.5 ± 3.7 | 37.2 ± 3.1 *** | 35.4 ± 3.3 | 37.6 ± 3.1 *** | 35.5 ± 3.4 | 37.4 ± 3.0 *** |
| OUEP [mL*L−1] | 41.8 ± 5.2 | 42.9 ± 3.8 | 41.3 ± 4.6 | 43.6 ± 4.0 * | 41.6 ± 4.8 | 43.2 ± 3.9 ** |
| OUE@VAT [mL*L−1] | 33.2 ± 3.8 | 35.4 ± 3.5 ** | 32.7 ± 3.6 | 35.9 ± 4.7 * | 32.9 ± 3.7 | 35.7 ± 4.1 *** |
| Ve [L*min−1] | 93.8 ± 11.6 | 90.7 ± 9.3 ** | 92.9 ± 20.4 | 87.4 ± 20.2 * | 93.3 ± 16.4 | 88.9 ± 15.7 * |
OUE—oxygen uptake efficiency; OUEP—oxygen uptake efficiency plateau; OUE@VAT—oxygen uptake efficiency at the ventilatory anaerobic threshold; Ve—minute ventilation; * p < 0.05 for post to pre value; ** p < 0.01 for post to pre value; *** p < 0.001 for post to pre value; data are presented as mean ± standard deviation (SD).